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1. SUMMARY
Verocytotoxigenic (shigatoxigenic) and enterohaemorrhagic
Escherichia coli, VTEC (STEC) and EHEC, produce a
toxin active on Vero cells in vitro. VTEC and EHEC have
been isolated from humans and different animal species,
mainly ruminants and pigs. The verocytotoxins, also
named shiga toxins (Stx), are active in vivo on the
endothelial cells of the blood vessels of the gastro-intestinal
mucosa, the kidneys, the brain, and other tissues of
humans and piglets, leading to fluid leakage or haemor-
rhages. Conversely, their role in diseases of young
ruminants remains unclear. Adult ruminants can also act
as asymptomatic carriers of VTEC and EHEC strains
similar to those causing diseases in humans. And they are
incriminated as an important source of direct or indirect
contamination of humans by the most famous EHEC strain
belonging to the O157:H7 serotype, through faecal con-
tamination of either foods of animal origin, or other
foodstuffs (fruit, vegetables, etc.), or the environment. But
dozens of non-O157 human and ruminant VTEC and
EHEC strains with similar general and virulence-associated
properties, have been described, whose epidemiology is
much less well understood. The purpose of this review
manuscript is to describe and compare the properties of
human, ruminant and food VTEC and EHEC strains.
2. INTRODUCTION AND SCOPE
Among the numerous classes of pathogenic Escherichia coli
the verocytotoxigenic (or shigatoxigenic) strains have cer-
tainly the widest notoriety. Their names originate from the
production of a toxin active on Vero cells in culture, which is
also related to the shiga toxin (Stx) of Shigella dysenteriae
type 1. Such verocytotoxigenic E. coli (VTEC) have been
known for half a century in the pig industry, as the cause of
oedema disease (ED) in recently weaned piglets. But until
the early 1980s they were of little significance, if any, in
human medicine. Why they have become so notorious in a
few years in comparison with the other pathogenic strains of
E. coli is certainly related to their high pathogenicity in
humans, with potentially serious clinical outcomes and to
their possible transmission to humans via foods of animal
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origin, especially ruminants. These particular E. coli strains
have therefore rapidly become a major concern and study
subject in human medicine, molecular biology and veterin-
ary medicine.
The purpose of this review is to (i) present the history and
definitions of VTEC (ii) describe the current knowledge on
their virulence properties and (iii) compare them based on
their origin. This reviewmanuscript is based on several review
articles and books recently published in the medical, micro-
biological and veterinary fields (Ludwig and Goebel 1997;
Scotland and Smith 1997; Hancock et al. 1998; Kaper et al.
1998a,b; Melton-Celsa and O’Brien 1998; Meng and Doyle
1998; Nataro andKaper 1998; O’Brien andKaper 1998; Paton
and Paton 1998; Mainil 1999; Duffy et al. 2000; Blanco et al.
2001; Brown et al. 2001; De Boer and Heuvelink 2001; Gyles
2001; Schmidt et al. 2001; Tozzi et al. 2001; Koronakis and
Hughes 2002; Thorpe et al. 2002) and on national and
international scientific reports (Anonymous 2003; Vernozy-
Rozand and Roze 2003). Other important past or recent
research papers are also cited in the text.
3. HISTORY AND DEFINITIONS
The history of VTEC follows two convergent paths. The first
pathway began in 1977, when the production of a cytotoxin
causing the death of Vero cells in culture (hence the name
verocytotoxin) was reported for strains of E. coli isolated from
humans suffering from diarrhoea and from piglets suffering of
postweaning ED (Konowalchuk et al. 1977). A few years later,
several human E. coli strains, including one strain previously
studied by the group of Konowalchuk (strain H30) were
reported to produce a similar cytotoxic effect on HeLa cells in
culture, which could be neutralized by an immune serum
produced against the Stx of S. dysenteriae type 1 (Stx), hence
the name shiga-like toxin (O’Brien et al. 1982). During the
following years, the identity of these two types of toxins was
recognized, as was their heterogeneity. The nomenclature
verocytotoxin andVTEC has been used since then by British
and Canadian teams, while the nomenclature shiga-like
toxins and shiga-like toxin-producing E. coli was used by the
American teams until 1996, when the names shiga toxins and
shigatoxigenic E. coli (STEC) were proposed, based on the
biological relation to the Stx produced by S. dysenteriae type1
(Calderwood et al. 1996).
The second pathway starts in 1983, with the report that a
rare E. coli serotype, O157:H7, was the cause of a distinctive
clinical entity, named at the time haemorrhagic colitis (HC)
and characterized by bloody diarrhoea (Riley et al. 1983). In
the following years O157:H7 E. coli strains were associated
with mild, undifferentiated to severe, bloody diarrhoea, with,
in some patients, sequelae such as a haemolytic uraemic
syndrome (HUS), characterized by renal failure, and a
thrombotic thrombocytopaenic purpura (TTP), possibly
with CNS2 involvement. As this E. coli serotype had been
initially associated with HC, the strains were named
enterohaemorrhagic E. coli (EHEC) and for many years
EHEC remained a clinical definition, synonym of O157:H7
E. coli causing HC. Progressively E. coli strains belonging to
other serotypes (026:H11, 0103:H2, 0111:H-, 0145:H-,
O157:H-, etc.) were associated with HC, HUS and TTP.
Although sometimes reluctantly, the original EHEC defini-
tion was widened to include those serotypes. Meanwhile, the
properties of the EHEC strains of the O157:H7 and other
serotypes were progressively uncovered. Among others,
production of the histological attaching/effacing (AE) lesion,
very close to the AE lesion caused by enteropathogenic E. coli
(EPEC) was recognized. Today the EHEC include all E. coli
strains, from humans and animals, producing Stx and AE
lesion, or harbouring the genetic information coding for
them. However, this definition is not universally accepted as
not all of these E. coli cause HC in humans. VTEC and
STEC are the names for the strains producing only Stx, like
the ED-associated E. coli in piglets.
4. SPECIFIC PROPERTIES OF EHEC AND
VTEC
The EHEC and VTEC possess general (serotypes, biotypes
and lysotypes) and specific properties (virulence-associated).
They are subdivided into different evolutionary lineages: the
EHEC-1 lineage comprises the O157:H7 and closely related
strains (e.g. O145:H-) that are highly pathogenic in humans
(HC, HUS and TTP) and are derived from the O55 EPEC.
The EHEC-2 lineage regroups all other EHEC strains
belonging to a wide variety of O serogroups (O5, O26, O103,
O111, O118, etc.) and of various pathogenicity in humans
(diarrhoea, HC and HUS); the VTEC-1 lineage strains
belong to the H21 serogroup (O91, O113, etc.) and are
pathogens in humans (HUS and TTP). The VTEC-2
lineage corresponds to all other VTEC of low or no
pathogenicity (asymptomatic carriage, diarrhoea and rare
HUS) in humans. This section will review the specific
virulence-associated properties of EHEC and VTEC, i.e. the
Stx, the AE lesion and the enterohaemolysins (Ehly).
4.1. The verocytotoxins
The E. coli Stx toxins consist of two groups: Stx1 are
antigenically very close to the Stx toxin of S. dysenteriae type
1 while Stx2 are more distantly related. Variants of Stx1
have been described which differ only slightly in their gene
sequences with no consequence on their antigenicity and cell
toxicity. The prototype Stx1 is produced by the E. coli
strains H19, H30 and EDL933. Several variants of Stx2
have also been described which differ much more from each
other in their antigenicity, toxicity and gene sequences. The
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classification of the Stx2 variants is confusing. It has been
proposed that five main biological variants are recognized
(Melton-Celsa and O’Brien 1998; Duffy et al. 2001; Thorpe
et al. 2002): Stx2 (human strains EDL933 and E32511),
Stx2c (human strains E32511 and B2F1), Stx2d [used
widely in the literature to describe several other (sub)var-
iants] identical to Stx2c but activatable by components
associated with the intestinal mucus (human strain B2F1),
Sx2e (porcine strains 412 and S1191) and Stx2f (human
strain H.I.8; previously named Stx2ev). VTEC strains can
produce one Stx toxin or two: Stx1 and Stx2 (strain
EDL933), Stx2 and Stx2c (strain E32511), two Stx2
subvariants (strain B2F1).
4.1.1. Structure/activity. The Stx are two subunit toxins:
the A subunit of c. 33 kDa is the biologically active part and
the B subunit, of c. 7Æ5 kDa is present in five copies and
binds to the specific-cell receptor. Following binding, the
Stx toxins are internalized by receptor-mediated endocytosis
and retrospectively transported into the endoplasmic reti-
culum after migration through the Golgi apparatus. The A
subunits then translocate into the cytoplasm using the Sec61
transmembrane protein complex and are activated after
cleavage of a 4 kDa C-terminal A2 peptide. The resulting
active A1 peptides have N-glycosidase activity and cleave a
purine residue from the 28S rRNA, altering the function of
the ribosomes, which are no longer able to interact with
elongation factors EF1 and EF2. The protein synthesis is
therefore inhibited within the target cells that will finally
die.
Not all Stx toxins are equally active on different cell lines.
If all Stx are highly toxic for Vero cells, the Stx1 and Stx2
only are fully toxic for HeLa cells, whereas the Stx2c and
Stx2d are partially (100 times less) and the Stx2e and Stx2f
are not (10 000-fold less). Conversely, only Stx2e and Stx2f
are fully toxic for Madin-Darby bovine kidney (MDBK)
cells, whereas the Stx2c and Stx2d are partially and Stx1 and
Stx2 are not. The cell target specificity of a Stx depends on
the amount of specific receptor(s) present on the cell
membrane: Gb3 (Gala1-4Gal) for Stx1 and Stx2 is present
on Vero and HeLa cells; Gb4 (GalNAcb1-3Gala1-4Gal) for
Stx2e and Stx2f is present on Vero and MDBK cells.
4.1.2. In vivo activity. In vivo the Stx are produced in the
intestines after colonization by the EHEC or VTEC, then
cross the intestinal wall (Stx2 more efficiently than Stx1)
and enter the blood stream (toxaemia). The main target cells
are the endothelial cells of small arteries, in the kidneys
(humans), brain (piglets and to a lesser extent humans),
gastro-intestinal mucosa (humans and piglets) and other
tissues (piglets). The consequences are fluid leakage and/or
haemorrhages leading to tissue lesions and clinical syn-
dromes (Table 1).
Nephrotoxicity is observed in humans as a sequela after
intestinal infection by EHEC or VTEC strains in 10% of
patients. The Stx cause chronic kidney damage leading to
dialysis and possible need for transplantation (HUS). HUS
is also characterized by microthrombus formation, throm-
bocytopaenia and haemolytic anaemia (Monnens et al. 1998;
Rose and Chant 1998). Although calves are frequently
infected by EHEC, HUS never develops as they lack
receptors on the endothelial cells of their blood vessels
(Pruimboom-Brees et al. 2000).
Neurotoxicity is observed first of all in piglets suffering
ED. Fluid leakage causes compression of the brain with loss
of coordination, lameness, paralysis and sudden death, as
main clinical signs (Gyles 2001). Neurological disorders can
also be observed in a few humans after intestinal infection by
EHEC or VTEC as part of a sequela known as TTP. TTP is
also characterized by haemolysis, thrombocytopaenia, renal
failure and a fluctuating fever (Hutchison et al. 1998; Rose
and Chant 1998; Duffy et al. 2000).
A number of workers have reported that the Stx1 and
Stx2 are enterotoxic, i.e. cause of fluid accumulation in
ligated intestinal loops in rabbits and therefore diarrhoea,
but this is still controversial and can vary according to the
animal species (Pruimboom-Brees et al. 2000). Today,
diarrhoea observed during infection by EHEC in humans
and calves is considered to be the consequence of formation
of the AE lesion (see below) and not the production of any
Stx. This is supported by the absence of diarrhoea in piglets
killed by ED and in humans infected by VTEC strains. On
the contrary, the haemorrhagic aspect of the diarrhoea in
humans, when present, would be the consequence of the
action of the Stx on the endothelial cells of the vessels
present in the intestinal mucosa. This is not the case in
calves as the endothelial cells of their blood vessels lack Stx
receptors (Pruimboom-Brees et al. 2000) and the role of Stx
in calves is still unknown.
In piglets fluid extravasation also cause oedema in the
eyelids, in the larynx leading to the development of a
characteristic hoarse squeal and, during the terminal stages
Table 1 Diseases caused by enterohaemorrhagic and verotoxigenic
Escherichia coli in humans and animals
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Healthy carriage in adults
Sheep/goats Healthy carriage in adults Healthy carriage in adults
Piglets – Oedema disease
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of a subacute ED, in the lungs leading to respiratory
distress.
4.1.3. Genetic basis. The A and B subunits of the Stx
toxins are coded by two different open reading frames
organized in one single transcriptional unit. Sequence
identity between the stx1 and stx2 prototype genes are 57%
in stxA and 60% in stxB genes at the nucleotide level
(Scotland and Smith 1997; Bastian et al. 1998; Pie´rard
et al. 1998; Mainil 1999) (Table 2a). The stx2 genes coding
for the different variants are more closely related to the
stx2 (74–96% overall identity) than to the stx1 genes (55–
60% overall identity). The more distantly related to the
stx2 genes are the stx2e variant genes and the stx2f variant
gene (Table 2b). Within each group the subvariants are
highly homologous (>95% sequence identity).
The stx1, stx2, stx2c and stx2d operons are present on
chromosomally located lambdoid phages. The stx2e, stx2f
and stx genes of S. dysenteriae are also located on the
bacterial chromosome, but not on phages. The transfer of
the stx1 and stx2 operons to recipient strains by phage
transduction has been performed in vitro and in vivo
(Mainil 1999; Toth et al. 2003). After synthesis the Stx
toxins are exported to the periplasm by a type II signal
sequence secretion system. The Stx1 toxins are mainly
present in the periplasm, while the Stx2 toxins are more
easily excreted into the environment at least in vitro. The
synthesis of Stx and Stx1, but not of the different Stx2, is
repressed at the transcriptional level by high iron
concentration via the Fur system and by high tempera-
ture.
4.2. The AE lesion
The AE lesion is a specific-histological lesion (Fig. 1) of the
gut caused by a class of pathogenical strains, named EPEC.
Most of these strains have been known for decades, but only
in the early 1980s was the production of this lesion fully
recognized and systematically studied (Moon et al. 1983;
Clarke et al. 2003). Subsequently, it was observed that
O157:H7 EHEC could produce a very similar lesion and the
definition of EHEC was extended to all E. coli strains
producing Stx and AE lesions.
4.2.1. Description. The production of AE lesions is the
result of a very specific and tightly regulated interaction
between the bacteria and the eucaryotic cell, the enterocytes
in vivo. This multistep event occurs in three stages. The first
step is the initial adherence of the bacteria to the surface and
microvilli of the host cells. In human EPEC this initial
adherence triggers the expression of several genes located on
Table 2 Overall % homology between the genes coding for the
A and B subunits of the stx, stx1 and stx2 toxin variants of Shigella
dysenteriae and Escherichia coli (Part A) and of the different stx2 gene
variants of E. coli (Part B)
(a)
% homology to stx1 genes (%) stx2 genes (%)
stx (A subunit) >99 57
stx (B subunit) >99 60
(b)
% homology to stx2c/d genes (%) stx2e genes (%) stx2f genes (%)
stx2 (A subunit) >95* 94 78
stx2 (B subunit) >95* 70 79
*Variable according to the subvariant Scotland and Smith (1997),
Bastian et al. (1998), Pie´rard et al. (1998) and Duffy et al. (2001).
Fig. 1 Intact intestinal microvilli and attaching/effacing lesions at the
electron microscope (15 680·). (a) Effacement of the microvilli of
the enterocyte; (b) intimate attachment of the bacteria to the
enterocyte; (c) pedestal structure; (d) internalization of a few bacteria
(author’s collection: Ann Me´d Ve´t, 2000, 144, 121–136; with
permission of the publisher)
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a pathogenicity island (Pai) on the chromosome, the locus of
enterocyte effacement (LEE), via a plasmid located regula-
tor. The identity of the primary adherence factor remains
unknown for animal EPEC and all EHEC strains.
The second step consists in sending signals into the
eucaryotic cell via a type III secretion system. The type III
secretion system and the translocated proteins are coded by
genes located on the LEE. Through phosphorylation of
several eucaryotic cell proteins the type III secreted proteins
cause polymerization of actin, cytoskeleton rearrangements
and effacement of the enterocyte microvilli (Fig. 1). Actual
modifications of biochemical pathways can differ between
EPEC and EHEC strains belonging to different serotypes
and to the target cells.
The third and final stage is an intimate adherence of the
bacteria to the nude cytoplasmic membrane of the entero-
cyte (Fig. 1). The bacterial adhesion is a LEE-encoded type
II secreted outer membrane protein, the intimin. Surpris-
ingly the cell receptor is also a bacterial protein (Tir for
translocated intimin receptor), coded by the LEE, type III
secreted and phosphorylated inside the enterocyte, before
integrating the eucaryotic cell membrane. At this stage the
rearrangements of the cytoskeleton are amplified, a pedestal
forms under the adhering bacterial cells (Fig. 1) and bundles
of actin filaments can be detected in and under the pedestal.
With some EPEC and EHEC, strains invasion of the
eucaryotic cells have been observed in vitro and in vivo
(Fig. 1). Although the actual significance of this observation
is unknown it may be related to the fact that the intimin can
also use b1 integrin as a receptor, very similar to the invasion
of Yersinia enterocolica.
4.2.2. The locus of enterocyte effacement. The genes
necessary and sufficient for the production of the AE lesion
are grouped on a 35–45 kb chromosomal DNA fragment,
which represents a type III Pai, originally named LEE. The
LEE comprises up to 50 genes and open reading frames, five
transcriptional units and three functional regions (Fig. 2).
The genes coding for the type III secretion system (esc and
sep genes) are located by convention in what is arbitrarily
called the left part of the LEE. The genes coding for the
type III secreted proteins (esp genes) are located in the right
part of the LEE. In the middle part of the LEE are present
the eae gene coding for the bacterial intimin adhesin and the
tir gene coding for its translocated receptor. The LEE of
human and animal EHEC and EPEC can differ in size,
numbers of genes and ORF, and insertion sites on the
chromosome (selC locus, pheU locus, pheV locus, etc.).
However, the internal organization of the genes on the LEE
is conserved (Kaper et al. 1998b; Goffaux et al. 2001a).
Variation has also been described within some LEE-
located genes. The number of variants of the eae gene has
dramatically increased as the original descriptions of the
prototype EPEC and EHEC LEE (Adu-Bobie et al. 1998;
Oswald et al. 2000; Zhang et al. 2002; Blanco et al. 2004a).
Currently, 14 variants, of relative importance and frequency,
have been identified by PCR: a, b, c, d, e, f, g, i, j, k, l, m,
h, n and other variants are still unnamed. In addition,
restriction variants of the amplified fragments exist for some
PCR variants: a1, a2, b1, b2, c1 and c2. Most variants differ
highly (<60–70% homology) in the 3¢-end third of the gene
while the 5¢-end two-thirds of the gene are highly
homologous (>90% homology). Moreover, the variants b2
and d are identical and the variants c2 and h are very closely
related. If the a and c1 variants are typical, but not
exclusive, of human EPEC and of O157:H7 EHEC,
respectively, the other variants are more or less widely
distributed in human and animal EHEC and EPEC.
selC
Chromosome 







genes coding for 
the type III 
secretion system
esp genes coding for 
the type III secreted 
proteins acting on the 
cytoskeleton





coding for the 
intimin adhesin
Fig. 2 Schematic description the locus of
enterocyte effacement (LEE) pathogenicity
island of the human enteropathogenic
Escherichia coli strain E2348/69 after Nataro
and Kaper (1998) and Duffy et al. (2000)
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Besides the eae gene, variants have also been described in
the tir and esp genes (a, b and c), while the esc and sep genes
are more conserved. The following associations between eae
(a, b, c1, c2 and e), tir and esp genes observed so far are: a/
a/a, b/b/b,c1/c/c, c2/a/a,e/b/b (China et al. 1999;
Goffaux et al. 2001b). Associations between tir, esp and
the other eae gene variants have not been studied so far to
our knowledge.
4.2.3. The diarrhoea. Although spectacular, the AE lesion
is not directly responsible for the diarrhoea observed during
infections with EPEC or EHEC. The actual reason for the
diarrhoea is still unknown, but several hypothesis have been
advanced according to in vitro and in vivo studies. These
include inhibition of sodium and chloride absorption,
activation of the major chloride channel in the microvilli,
opening of the tight junctions, increased paracellular
permeability, production of another toxin, inflammatory
response in the mucosa and production of cytokines. The
cause of diarrhoea may differ between strains of different
serotypes, according to the biochemical modifications initi-
ated within the eucaryotic cells.
4.3. The enterohaemolysins
Several types of haemolysins (a, b, etc.) are produced by
invasive, uropathogenical and enterotoxigenic E. coli. More
recently, haemolysins active only on washed red blood cells
have been associated with EHEC strains called Ehly.
Different Ehly have been described in E. coli, but one is
specific of EHEC strains, the so-called EHEC-Ehly or Ehx
(Karch et al. 1998; Beutin 2000).
4.3.1. Structure/activity. The Ehx belongs to the RTX
(repeats in ToXin) family of toxins, like the a-haemolysin
(a-Hly). The Ehx, like the a-Hly, is a monomeric pore-
forming toxin that inserts into the cytoplasmic membrane
of the eucaryotic target cells and creates pores. It is
exported by a type I secretion system, but remains attached
to the bacteria in contrast to a-Hly, probably as a
consequence of a mutation in the genes coding for the
transport mechanism.
4.3.2. In vivo activity. Despite the observation of a
preferential association with the development of HUS in
humans, the actual contribution of the Ehx to the patho-
genesis of EHEC and VTEC remains unclear.
4.3.3. Genetic basis. The Ehx is encoded by four genes
(ehxC, ehxA, ehxB and ehxD) located on a plasmid of c.
60 Mdal (pEHEC plasmid). The structural gene ehxA sows
c. 60% homology with the hlyA gene coding for the a-Hly.
The a-Hly (HlyA), as all RTX toxins, is secreted by a type I
secretion system involving the participation of the HlyB and
HlyD proteins. HlyB is a membrane-bound ATPase provi-
ding energy for the secretion of the HlyA. HlyD forms a
channel through the bacterial membranes with the help of
the TolC outer membrane protein through which HlyA is
secreted. The ehxB and ehxD genes appears to be deficient
in the secretion of EhxA and can be complemented by the
hlyB and hlyD genes. In that case Ehx is excreted into the
supernatant and gives an a-Hly like haemolysis.
Other genes are located on the pEHEC plasmid coding for
a type II secretion system (etp genes), for a catalase-
peroxidase (katP gene) and for a secreted serine protease
(espP gene in O157:H7 EHEC or pssA gene in O26:H11
EHEC). The pEHEC plasmid carrying the ehx and etp genes
is present in all O157:H7 EHEC strains, in a majority of
O26:H11 EHEC strains and in variable proportion of EHEC
strains belonging to other serotypes. The katP, espP and
pssA genes are, however, present on a majority, but not all,
pEHEC plasmids (Karch et al. 1998; Beutin 2000).
5. EPIDEMIOLOGY OF EHEC AND VTEC
IN HUMANS
Human EHEC and VTEC strains belong to three classes
on a clinical basis: (i) those highly infectious in humans,
but only exceptionally in animals (essentially EHEC-1 and
VTEC-1) (ii) those frequently associated with diseases in
humans and animals (essentially EHEC-2) and (iii) those
more rarely associated with disease in humans or animals
(essentially VTEC-2). The most famous EHEC strains
belong to the EHEC-1 lineage and to the O157:H7
serotype.
National surveillance programmes tend to concentrate on
the O157:H7 EHEC. Infections of humans with the
O157:H7 serotype occur most frequently as food-borne
outbreaks in communities, such as families, schools, elderly
homes and day care centres. These outbreaks are for
reasons unknown primarily restricted to North America
and UK. They are rare in continental Europe, South
America, Asia (Japan), Oceania and Africa. Mainly indi-
vidual cases are reported in these other locations. The food
vehicles are mainly of ruminant origin such as raw,
inadequately cooked meat products or unpasteurized milk.
O157:H7 EHEC are carried by healthy cattle and, to a
lesser degree, other ruminants in the gastro-intestinal tract.
Contamination occurs during milking or slaughter and
processing of the carcass. The primary colonization site
appears to be the recto-anal junction (Rice et al. 2003).
The faecal shedding lasts for <2 months in most animals,
but it is believed that some cattle are effectively colonized
for longer periods of time. Food vehicles can also originate
from other ruminants (unpasteurized goats cheese, veni-
son, etc.).
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Increasingly, infections originate from nonruminant
sources, which have been contaminated directly or indirectly
by ruminant faeces or by infected humans. Thus transmis-
sion occurs through consumption of nonruminant meat and
meat products (poultry meat sandwiches, cold pork meat,
salami, etc.) and of fruit and vegetables (potatoes, cabbages,
sprouts, cole slaw and unpasteurized apple cider) or via
nonfood-borne routes (water in swimming pools or lakes,
mud, direct animal contacts including sporadically
nonruminants and person-to-person contacts). Although
the sources are numerous, they have one common feature –
the foods and food products have been inadequately
prepared, stored or cooked, allowing survival and growth
of the O157:H7 EHEC.
Infections, outbreaks and individual cases, with other
serotypes occur to a lesser extent, although they represent
the majority of cases in some areas (continental Europe for
instance). The serogroups O26, O103, O111 and O145 are
the most frequent. The sources of infection for humans, the
rate of carriage in ruminants and the true incidence in
humans of these non-O157:H7 cases are impossible to
estimate, as surveillance programmes include only the
nonsorbitol-fermenting O157:H7 EHEC.
Human infections with VTEC (serogroups O48, O91,
O104 and O113) have also been reported, but more recently.
They do not seem to find their origin in food consumption,
although similar strains can be isolated from ruminant faeces
and intestinal content and from foodstuffs. It is important to
emphasize that porcine VTEC causing ED in weaned piglets
differ by their general and specific properties and that
porcine VTEC should be considered as very unlikely
zoonotic agents.
6. PROPERTIES OF EHEC AND VTEC FROM
DIFFERENT ORIGINS
As porcine VTEC responsible for ED do not represent any
important public health concern and as the epidemiological
significance of EHEC and VTEC described outside the
ruminant animal species is still largely speculative (Mainil
1999; Gyles 2001; Wasteson 2001), this section will focus on
EHEC and VTEC isolated from humans, ruminants and
foods (Tables 3–5).
6.1. From humans
Humans are infected by EHEC which are responsible for
HC, HUS and TTP and by VTEC, which are responsible
for HUS and TTP only (Table 1). Asymptomatic carriage
also exists, especially of VTEC strains. Human EHEC and
VTEC belong to an ever-increasing list of O serogroups and
serotypes. The most well-known is, of course, the O157:H7
EHEC and among the VTEC serotypes the most famous
ones are O91:H21 and O113:H21. But more than 130 other
O serogroups in combination with various H serogroups
have been described in the literature and new ones are
described each year (Blanco et al. 2004a). More than 100
O:H serotypes have been isolated from patients with HUS.
The incidence of the serotypes varies geographically.
Infection with O157:H7 EHEC has been directly or
indirectly associated with cattle and other ruminants.
Nevertheless, direct and indirect human-to-human contam-
ination also occurs frequently, especially during an outbreak.
Conversely, the source of human contamination by other
serotypes of EHEC and VTEC (O26, O91, O103, O111,
O113, O118 and O145) is never identified in most instances,
although many human serotypes have also been isolated
from ruminants.
The O157:H7 and non-O157 EHEC and VTEC produce
Stx1 and/or Stx2, in relatively similar proportions, although
differences have been observed, probably because of
geographical and population sample variations. The isolates
producing Stx2 are more often associated with HUS
than those producing only Stx1. The stx2 variants are
mainly stx2, stx2c and stx2d. There is some degree of
association between the serotypes and the stx gene variants.
In only very few cases the variants stx2e and stx2f have been
described.
Most human strains are EHEC and their eae genes belong
most frequently to the following variants: b, c1, c2, e. For
Table 3 Comparison of the properties of O157 enterohaemorrhagic Escherichia coli (EHEC) isolated from humans, animals and foodstuffs
Origin (disease) Stx profiles Stx2 variants LEE Ent-Hly and pEHEC (%)
Humans
(HC, HUS, TTP)
Stx1, Stx1/Stx2, Stx2 Stx2, Stx2c eae c1, tir c1, esp c1 100
Calves (diarrhoea) Not associated Not relevant Not relevant Not relevant
Cattle (healthy) Stx1, Stx1/Stx2, Stx2 Stx2, Stx2c eae c1, tir c1, esp c1 100
Sheep/goats
(healthy)
Stx1, Stx1/Stx2, Stx2 Stx2, Stx2c eae c1, tir c1, esp c1 100
Foods Stx1, Stx1/Stx2, Stx2 Stx2, Stx2c eae c1, tir c1, esp c1 100
HC, haemorrhagic colitis; HUS, haemolytic uraemic syndrome; TTP, thrombotic thrombocytopaenic purpura; Stx, shiga toxins; LEE, locus of
enterocyte effacement; Ent-Hly, O157 enterohaemolysin.
VEROTOXIGENIC E. COLI 7

















instance, all O157 and O145 EHEC harbour the c1 variant
and all O26 EHEC, the b variant of the eae, tir and esp genes.
In many others the c2 variant of the eae gene and the a
variant of the tir and esp genes are associated with the O111
serogroup while the e variant of the eae gene and the b
variant of the tir and esp genes are associated with the O103
serogroup (China et al. 1999; Goffaux et al. 2001b; J. Mainil
et al., unpublished data3 ).
All O157:H7 EHEC are positive for the Ehx Hly and the
pEHEC plasmid. Two-thirds of the EHEC and VTEC of
other serotypes are positive for the Ehx (% variable
according to the O serogroup) whose encoding genes are
often located on a pEHEC-like plasmid.
6.2. From cattle
Infections in cattle with EHEC/VTEC show two distinct
patterns, with some strains producing diarrhoea in young
calves of 2 weeks to 2 months of age and other strains being
carried asymptomatically by adult animals (Table 1).
6.2.1. From diarrhoeic calves. Strains causing diarrhoea
in calves belong almost exclusively to the EHEC pathotype.
Like human strains, they belong to an always extending
number of serotypes, many of which are also associated with
diseases in humans. On the contrary, O157:H7 EHEC have
been exceptionally associated with diarrhoea in young calves
(Dean-Nystro¨m et al. 1998; Brown et al. 2001; Kang et al.
2004). The most important calf serotypes are O5:H-,
O26:H-, O26:H11, O111:H- and O118:H16. Data on VTEC
strains causing disease in calves are rare. When they have
been reported they belonged to other serotypes (O8:H8,
O20:H19; O113:H21) than the EHEC. Some of these VTEC
serotype have been isolated from human cases of HUS
(O113:H21).
The majority (>85%) of these bovine EHEC are positive
for the stx1 gene only. When stx2-positive, bovine EHEC
contain the stx2 or stx2c gene variants. Conversely, bovine
VTEC are positive for the stx1 and/or stx2 genes without
any apparent preference. Their stx2 gene variants have not
been identified to our knowledge.
Table 5 Comparison of the properties of verocytotoxigenic Escherichia coli isolated from humans, animals and foodstuffs
Origin (disease) Frequent serogroups (serotypes) Stx profiles Stx variants Ent-Hly and pEHEC
Humans
(HUS, TTP)
O91, O113, O128, O146, etc.
(H21+/H21))
Stx1, Stx1/Stx2, Stx2 Stx2, Stx2c, Stx2d Variable
Calves (?) O8, O20, etc. Stx1, Stx1/Stx2, Stx2 Not reported Variable
Cattle (healthy) O113:H21, etc. Stx1, Stx1/Stx2, Stx2 Stx2, Stx2c Variable
Sheep/goats (healthy) O6, O91, O128, O136, O146, etc. Stx1, Stx1/Stx2, Stx2 Stx1c, Stx2d Variable
Foods Very many Stx1, Stx1/Stx2, Stx2 Rarely reported Not reported, Stx2, Stx2c
HUS, haemolytic uraemic syndrome; TTP, thrombotic thrombocytopaenic purpura; Ent-Hly, O157 enterohaemolysin.

















Stx1, Stx1/Stx2, Stx2 Stx2, Stx2c,
Stx2d
eae b/tir b/esp b,
eae c2/tir a/esp a,
eae c1/tir c1/esp c1,






Stx1, Stx1/STx2, Stx2 Not reported eae b/tir b/esp b,







Stx1, Stx1/Stx2, Stx2 Stx2, Stx2c eae b/tir b/esp b,
eae c2/tir a/esp a,
eae c1/tir c1/esp c1,







Stx1, Stx1/Stx2, Stx2 Stx1c, Stx2d eae b/tir b/esp b,
eae c2/tir a/esp a,
eae c1/tir c1/esp c1
25 (?)
Foods Very many Stx1, Stx1/Stx2, Stx2 Rarely reported,
Stx2, Stx2c
Not reported Not reported
HC, haemorrhagic colitis; HUS, haemolytic uraemic syndrome; TTP, thrombotic thrombocytopaenic purpura; Stx, shiga toxins; LEE, locus of
enterocyte effacement; Ent-Hly, O157 enterohaemolysin.
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The majority (80%) of bovine EHEC from diarrhoeic
calves are positive for the eaeb gene variants of the eae, tir
and esp genes. The second most frequent variants (20%) are
the eaec2 gene along with the tira and espa genes. The
typing results are homogeneous in some serogroups (O5:H-,
O26:H11; O118:H16), but not in others (O111:H-). Other
variants have not yet, or rarely, been recorded. Also
important to note is the identity of the eae, tir and esp
genes of bovine diarrhoea-associated and human EHEC
belonging to the same serotype (China et al. 1999; Goffaux
et al. 2001b; J. Mainil et al., unpublished data).
Several bovine EHEC and VTEC associated with diar-
rhoea in young calves are also positive for the Ehly
phenotype or genetically for the EHEC Ehly, but the actual
proportion can vary from region to region.
6.2.2. From healthy cattle. More than 120 O serogroups
of EHEC and VTEC, in combination with different H
serogroups, have been isolated from healthy cattle. Of these,
more than 100 have been described in humans. More than
one type of EHEC and VTEC strains can be isolated not
only on the same farm, but also from the same animal.
Reported prevalence in cattle varies greatly according to the
country and to the detection method (PCR-based methods
always give much higher results). Animal prevalence varies
from 0Æ1 to 63% and herd prevalence, between 0Æ3 and 87%
in herds. The great majority of isolates are VTEC and only a
minority are actually O157:H7 EHEC.
The O157:H7 EHEC prevalence is always higher in the
USA than in Europe: 2–20% vs 0–3% as herd prevalence,
representing nevertheless <1% of the animals. The bovine
O157:H7 EHEC are identical to the human strains in the stx
genes, in the LEE genes and in the pEHEC plasmid. In
addition, the same lysotype is dominant amongst O157:H7
EHEC isolated in Belgium from humans, healthy cattle and
beef meat (Daube et al. 1999). Conversely, bovine O157:H7
EHEC on one farm and even in one animal can belong to
multiple pulsotypes as evidenced by PFGE. Comparison of
PFGE of human and bovine O157:H7 EHEC lead to the
hypothesis that not all bovine O157:H7 EHEC are a major
threat and associated with severe diseases in humans
(Liebana et al. 2003). Isolation of O157 non-EHEC non-
VTEC E. coli has also been reported (Rogerie et al. 2001).
The most frequent non-O157 EHEC isolated from
healthy cattle belong to the following O serogroups: O5,
O26, O103, O111, O118 and O145. There exist geographical
variations in the predominance of the different serotypes.
Most surveys indicate that they are also similar to human
isolates beyond the serotype. They are stx1, stx2 and/or
stx2c-positive and the eae gene belongs to the same group of
variants. As stx and eae gene profiles are correlated to the O
serogroup bias can occur in some surveys if one serogroup
predominates. More than half of them are positive for the
production of Ehx and for the presence of the ehx genes on a
pEHEC-like plasmid.
Some VTEC isolated from healthy cattle are also similar
to human VTEC associated with disease (VTEC-1 lineage)
including HUS by their serotypes (O91:H21; O113:H21,
etc.) and pathotypes (stx1, stx2 and/or stx2c), but can differ
according to the pulsotype (Pradel et al. 2001). However,
most of them (VTEC-2 lineage) belong to serotypes that
have been rarely reported from humans or are of low
pathogenicity in humans.
6.3. From other ruminants
The EHEC and VTEC have also been isolated from other
domestic ruminants (sheep and goats) and from wild
ruminants, initially from healthy carriers (Table 1).
Although the prevalence of O157:H7 EHEC in faeces or
intestinal contents of healthy sheep and goats is lower than
in cattle, their profiles do not differ from the profiles of
human and bovine strains. Therefore sheep and goats also
represent a potential source of contamination for humans.
Transmission to humans has been reported essentially via
consumption of raw milk or cheese (Mainil 1999; Blanco
et al. 2001; Brown et al. 2001; Blanco et al. 2003).
In sheep and goats, non-O157:H7 EHEC and VTEC are
detected much more often than O157:H7 EHEC: 43–95%
and 7–95% of faecal samples respectively. Even more in
cattle, VTEC are more numerous than EHEC and one
animal can excrete more than one type of strain. Ovine and
caprine non-O157 EHEC and VTEC belong to human
disease-associated serotypes (O26:H11, O49:H-, O156:H-
for EHEC and O91:H-, O128:H2, O146:H21 for VTEC), or
to more sheep/goat-specific serotypes (O52:H12, O156:H25,
OX177:H11 for EHEC and O6:H10, O136:H20 for VTEC).
The majority of isolates are positive for the stx1 gene (mainly
the stx1c variant); a minority for the stx2 gene (mainly the
stx2d variant) (Ramachandran et al. 2001; Brett et al. 2003).
Several eae gene variants have been identified in a similar way
to that in human and cattle EHEC and the ehx gene is
present, but in only c. 25% of cases. The stx and eae gene
profiles are also correlated to the serogroup (Blanco et al.
2003). The role of non-157:H7 EHEC, and maybe VTEC, in
diseases in lambs and goat kids is unknown.
The O157:H7 and non-O157:H7 EHEC and VTEC are
also present in farmed and free wild ruminants, but preval-
ence varies greatly depending on geography. O157:H7 EHEC
from deer has been associated with a limited number of
human outbreaks. On the contrary, they do not appear to be
an important source of contamination for domestic cattle, as
their pulsotypes are different (Brown et al. 2001). Moreover,
O157 VTEC or non-EHEC–non-VTEC E. coli can often be
isolated from wild ruminants leading to confusion in report-
ing. In general, and particularly in Belgium (Pirson et al.
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2000; Canivet et al. 2002), VTEC are more frequent than
EHEC. The role of these different strains in the development
of pathologies in the wild ruminants is unknown.
6.4. From foods
Raw foods of animal origin are the most likely to be
contaminated by EHEC and VTEC. Milk becomes
contaminated during milking, carcasses during slaughter
and further processing at the abattoir, and cross-contamin-
ation may occur in butcher’s premises. The level of
contamination is linked primarily to the level of intestinal
infection, faecal excretion and, of course, general hygiene.
Because O157:H7 and other EHEC strains are particularly
resistant in the environment (Duffy et al. 1999; McDowell
and Sheridan 2001; Brown et al. 2002), secondary contam-
ination food can occur at many places within the food chain.
If 30% of beef carcasses of O157:H7 EHEC excreting
animals are contaminated, a tenth of carcasses of nonex-
creting animals become, almost certainly by cross-contam-
ination during the slaughter process.
Survey results can be difficult to compare because
researchers use different protocols for sampling, screening,
isolation, identification and typing procedures. For instance,
positive results obtained by PCR tend to be several times
higher than those obtained with other methodologies. In
addition, enrichment, isolation and identification methods
for non-O157:H7 EHEC and VTEC are not as reliable. As a
general rule, non-O157:H7 EHEC and VTEC are more
frequent than the O157:H7 EHEC. Conversely, ratios
between EHEC and VTEC are variable.
Most European countries report isolation rates of
O157:H7 EHEC from beef carcasses and from raw beef
products between 0 and 4%. Results are similar in the USA,
but can occasionally be higher (up to 36%) in less developed
countries. Isolation rates from raw milk vary between 0 and
10%. Isolation rates of non-O157 EHEC and VTEC from
meat products and milk are higher (between 1 and 40%),
even in developed countries.
When reported, the combination of stx1, stx2 and eae
genes and serotypes are identical to those identified in
EHEC and VTEC from humans and from healthy cattle.
The most frequent stx2 gene variants identified are stx2 and
stx2c (Guth et al. 2003), but most surveys do not type the stx
and eae gene variants.
In other ruminant carcasses and meat products, the
situation is even less clear, because official surveillance is not
undertaken. General isolation rates of EHEC and VTEC are
under 5% and O157:H7 EHEC are very rare as most fial to
isolate these strains. Serotypes of non-O157 EHEC and
VTEC isolated from lamb and deer meat are similar to those
detected in living animals, but no typing results of the stx
and eae genes have been reported to our knowledge.
In nonruminant meat and meat products (pork and
poultry for instance) non-O157 EHEC and VTEC can be
frequently isolated (1–50%), but O157 EHEC are very rare,
even absent, in most of the surveys. Most strains belong to
host-specific serotypes and pathotypes. O157 E. coli lacking
the stx and/or the eae genes have also been isolated from
nonruminant meat products and can lead to confusion in
reports.
7. CONCLUSIONS
The role of ruminants as direct and indirect source of
contamination of humans by O157:H7 EHEC is today
beyond any doubt, although human-to-human contamin-
ation also clearly exist. Less data are available for most of the
other strains. Very little is known about the dynamics of the
carrier state, the epidemiology in cattle and in humans, and
the actual host specificity of the non-O157:H7 EHEC and
VTEC strains.
Identical strains have been isolated from healthy cattle,
young and adult animals, and diseased humans, favouring
the hypothesis of animals as sources of contamination for
humans. One cannot exclude the possibility that bovine
and human strains of EHEC and VTEC strains belonging
to the same serotype and pathotype could be grouped
differently on the basis of their host specificity (Mainil
1999; Brown et al. 2001; Pradel et al. 2001; Liebana et al.
2003). A first group would include calf-specific strains,
while other strains would be human-specific. Finally a
third group would comprise strains devoid of host
specificity. This hypothesis is supported to some extent
by the PFGE comparison of strains. Their host specificity
in pathology and in carriage, if any, would not reside in the
Stx, in the LEE-located genes, nor in the pEHEC plasmid-
located genes. However, it would reside in the production
of adhesion acting as specific-colonization factors of the
host intestinal tract. Candidates have been described for
different EHEC and VTEC, but their role in the
colonization of the mucosa is unconfirmed (Paton et al.
2001; Szalo et al. 20014 ).
Future research efforts must not only target improved
diagnosis, traceability and prevention of O157:H7 EHEC
infections in humans, ruminants and nonruminant animals,
but also focus on the non-O157 EHEC and VTEC
combining microbiological, medical and veterinarian studies,
to bring better understanding their epidemiology, aetiology,
virulence properties and host specificity.
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